These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 10718788)
1. Excretion of fluvoxamine into breast milk. Hägg S; Granberg K; Carleborg L Br J Clin Pharmacol; 2000 Mar; 49(3):286-8. PubMed ID: 10718788 [No Abstract] [Full Text] [Related]
2. Excretion of paroxetine into breast milk. Ohman R; Hägg S; Carleborg L; Spigset O J Clin Psychiatry; 1999 Aug; 60(8):519-23. PubMed ID: 10485633 [TBL] [Abstract][Full Text] [Related]
3. Fluvoxamine concentrations in breast milk and in maternal and infant sera. Arnold LM; Suckow RF; Lichtenstein PK J Clin Psychopharmacol; 2000 Aug; 20(4):491-3. PubMed ID: 10917415 [No Abstract] [Full Text] [Related]
4. The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants. Kristensen JH; Hackett LP; Kohan R; Paech M; Ilett KF J Hum Lact; 2002 May; 18(2):139-43. PubMed ID: 12033075 [TBL] [Abstract][Full Text] [Related]
5. Fluvoxamine in breast-milk and infant development. Yoshida K; Smith B; Kumar RC Br J Clin Pharmacol; 1997 Aug; 44(2):210-1. PubMed ID: 9278215 [No Abstract] [Full Text] [Related]
12. Clinical effects of fluvoxamine on panic symptomatology. Pols H; Zandergen J; de Loof C; Fernandez I; Griez E Acta Psychiatr Belg; 1993; 93(3):169-77. PubMed ID: 8030430 [TBL] [Abstract][Full Text] [Related]
13. Piloerection induced by replacing fluvoxamine with milnacipran. Hori S; Matsuo N; Yamamoto A; Hazui T; Yagi H; Nakano M; Suzuki Y; Miki A; Ohtani H; Sawada Y Br J Clin Pharmacol; 2007 Jun; 63(6):665-71. PubMed ID: 17324248 [TBL] [Abstract][Full Text] [Related]
14. Excretion of psychoactive drugs into breast milk. Pharmacokinetic principles and recommendations. Pons G; Rey E; Matheson I Clin Pharmacokinet; 1994 Oct; 27(4):270-89. PubMed ID: 7834964 [TBL] [Abstract][Full Text] [Related]
15. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Ilett KF; Hackett LP; Dusci LJ; Roberts MJ; Kristensen JH; Paech M; Groves A; Yapp P Br J Clin Pharmacol; 1998 May; 45(5):459-62. PubMed ID: 9643618 [TBL] [Abstract][Full Text] [Related]
16. An open trial of fluvoxamine therapy for panic disorder complicated by depression. Spiegel DA; Saeed SA; Bruce TJ J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679 [TBL] [Abstract][Full Text] [Related]
17. Distribution and excretion of sertraline and N-desmethylsertraline in human milk. Kristensen JH; Ilett KF; Dusci LJ; Hackett LP; Yapp P; Wojnar-Horton RE; Roberts MJ; Paech M Br J Clin Pharmacol; 1998 May; 45(5):453-7. PubMed ID: 9643617 [TBL] [Abstract][Full Text] [Related]
18. Duloxetine in the treatment of panic disorder. Crippa JA; Zuardi AW Int J Neuropsychopharmacol; 2006 Oct; 9(5):633-4. PubMed ID: 16288682 [No Abstract] [Full Text] [Related]
20. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia. Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]